chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On Dec 28 - three hours after vaccine - started getting pain near injection site. It ached. 8:30PM that night I started getting itching from the midback to top of head on left side. Not left arm just the back, neck and face of left side. No rashes but a little red because I scratched. Then I noticed some bumps on my left side of my face and one hive on each knee and one hive on left shoulder. Telemed visit with dr. - took Benadryl - 25 mg. - within one hour of symptoms - at 9:00 pm per dr. Woke up next morning and had intense fatigue; muscles and back were really achy. Couldn't move my muscles very well. Felt like the wind had been knocked out of me. Bouts of itchiness. Slept throughout the day. That helped. But then had headache start - felt like a circle where my temples are to the back of my head and that is where is stayed. Next day - no fever and  but my symptoms improved except still had the symptoms but they had improved. Went to work on Wednesday because it started to go away - on and off headache - felt foggy. Bouts of itchiness and felt physically weak because my muscles had gotten so so tight. Felt a physical weakness for five more days. Headache went away by Wednesday night (Dec 30th). Itchiness went away. Three days symptoms went away although the physical weakness lingered until 5th  day. Used a heating pad for my muscles to help relax them.
This case was reported by a consumer via call center representative and described the occurrence of papular rash in a 65-year-old female patient who received SHINGRIX for prophylaxis. The patient had a Family History of sulfonamide allergy and allergic reaction to antibiotics (family history of Sulfa and Erythromycin allergy, caused red from head to toe and hard to breath). Previously administered products included ZOSTAVAX (received about 5 years ago). On 31st May 2018 16:30, the patient received the 1st dose of SHINGRIX. On 31st May 2018 19:30, 3 hrs after receiving SHINGRIX, the patient experienced papular rash. On an unknown date, the outcome of the papular rash was not recovered/not resolved. It was unknown if the reporter considered the papular rash to be related to SHINGRIX. Additional details were provided as follows: The patient did not receive any concomitant medications. The patient received SHINGRIX in the left arm at the physician office. At around 19:30 hours, the patient experienced 6 bumps in an arch pattern from the left side of her neck downward to the right side of her. The patient did not reported this to her physician, but she was encouraged to do so.
Pt received Pfizer vaccine x2 on 2/14/21 at 1/24/21. Pt found to be COVID + on 5/4. Pt admitted to the hospital on 5/3/21 d/t a fall which currently treating for UTI. Currently asxmatic COVID and not hypoxic.
Extreme fatigue, fever, headache, and body aches approximately 8 hours after shot. Lasted about 24 hours.  Painful, red, and swollen right arm with a rash approximately 4 hours after shot and still continues 3 days later.
1230PM mom states pt awoke from nap-alert, no fever shaking of body & arms described as shivering, hands cold to touch; pt fussy cry x 1; advised APAP & contacting MD; ER visit 4JAN93 MD dx early OM, fever; dx poss neurological reaction; sz
Fainted and felt dizzy about 15 to 20 minutes after having vaccine. patient asked for water which was provided.  Bp was checked (105/65).  Patient was advised to have a snack and stay seated until he felt better.  About ten minutes later his symptoms had improved.
Caused a period 2 weeks earlier (I am on a very normal cycle) with excessive bleeding and clots like never ever before. Frist few period after the vaccination were very heavy and painful, and out of cycle. The cycle has remained unstable since.
Patient received pneumovax at 13:31 on 06/06/2005.  CRP 8.3.  Patient received Benadryl 50mg - 22:00 on 06/06/2005.  On 06/07/2005 - marked area of inflammation, 8 inches on whole left arm with redness and tenderness.  Also painful.  Patient was ordered Benadryl 25-50mg by mouth every 8 hours, Morphine 2-4mg as needed for pain.  Tylenol 650mg every 4-6 hours as needed for pain.  Ice pack to left arm and elbow, swelling starting to decrease.
Terrible taste in mouth after flu shot. Dizziness. Heavy chest, tight feeling in chest. Weaknessm shakiness. Nausea. Eleveated BP. Warm feeling skin very reddened. Seen in ER. Givent BENADRYL.
pt states she lost mobility in arm, pt states she has pain from shoulder to elbow, pt states she had to do physical tx, pt states she was dx with turner syndrome
This case was reported by a nurse via call center representative and described the occurrence of injection site itching in a 55-year-old female patient who received ENGERIX B (batch number L4DF7, expiry date 15th January 2019). On 14th October 2016, the patient received the 1st dose of ENGERIX B (intramuscular) 1 ml. On 14th October 2016, less than a day after receiving ENGERIX B, the patient experienced injection site itching, injection site erythema, adult use of a child product, wrong injection technique and off label use. On an unknown date, the outcome of the injection site itching and injection site erythema were unchanged and the outcome of the adult use of a child product, wrong injection site technique and off label use were unknown. The reporter considered the injection site itching and injection site erythema to be probably related to ENGERIX B. Additional details were provided as follows: This case was not previously reported to anyone. On Friday, at 11:00, the patient received ENGERIX B on left deltoid. The reporter reported that two, 0.5 ml doses of the paediatric strength were drawn up into one syringe and injected into the adult patient. The patient received a total of 1 ml of product. This led to an off label use, inappropriate age at vaccine administration and wrong injection technique. On the same day, the patient experienced localized itching and erythema approximately one inch around the injection site. The reporter indicated that the patient sent her a picture of the injection site and would be glad to send it.
Information has been received regarding a case in litigation, from a lawyer, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 23-JUN-2013, the patient was vaccinated with a dose of ZOSTAVAX as permanent prevention and protection against shingles and zoster-related injuries (prophylaxis). (Strength, dose, route of administration, anatomical location, lot # and expiration date were not reported) due to a health care professional recommendation. On an unknown date, the patient experienced shingles (herpes zoster) and other zoster-related injuries despite being inoculated with the ZOSTAVAX vaccine (vaccination failure). On 03-OCT-2016, the patient was treated by a physician for shingles. It was also reported that the patient suffered serious physical, emotional and economic damages as a result. In addition, the patient would continue to suffer ongoing injuries, included but not limited to: mental and physical pain and suffering (Emotional distress and pain), extensive medical care and treatment for these injuries, significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of pre-existing conditions and activations of laten conditions, lost wages, loss of earning capacity and other losses and damages. At the time of report, the patient was not recovered from emotional distress and pain, and the outcome of the patient regarding the vaccination failure, herpes zoster, quality of life decreased and the pre-existing unspecified conditions aggravated was unknown. The reporter considered all aforementioned adverse events to be related to ZOSTAVAX. The reporter considered the events to be disabling, life-threatening and medically significant.
All of this started in April and I started getting light headed like I wanted to pass out, that is why I went to the Cardiologist which is why we started the testing. After he did all the testing, he wanted me to go see a neurologist who did an EEG of my head in May, After all the testing they have done they found out electrical activity in the frontal lobe on on the left side. This was done in June, and I received medications June for Sparks because people in their 70's get this. The lightheadedness started after the 4th dose and that is why I am now on medication for both my heart and my brain.  It seems to be under control now, but now I am having trouble breathing.  I do not know if this came about because of the booster vaccine but this is what has happened afterwards.
Painful arm injection site (for 24 hrs) followed a week later by severe shoulder ache and radiating upper back pain, tingling in muscles and slight numbing feeling down left arm.
The Pfizer COVID-19 Vaccine vials were reconstituted with 1.6mL vs. 1.8mL of normal saline.  This resulted in the patient receiving 33mcg of active vaccine component in the 0.3mL dose instead of the EUA labeled 30mcg.  This has been disclosed to the DOH and the patient.  Patient reports feeling fine, no adverse side effects.  Reporting through VAERS is required by the DOH given the increase in dose administered.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. It was reported that the patient had shingles on his ankles approximately 8 years before (on an unspecified date in October 2005). On 29-OCT-2013 the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiration date, dose were not reported). The patient stated that he had a tingling sensation in his ankles at the time of the report (on an unspecified date in October 2013). The outcome of tingling sensation in ankles was unknown. The patient sought medical attention, he contacted pharmacist. The relatedness between tingling sensation in ankles and ZOSTAVAX was not reported. Additional information has been requested.
Shortly after receiving vaccine started getting warts - per mom. Worse after 2nd GARDASIL.
Developed "welts" or hives on chest, neck, stomach, & face day p/DTP. Seen by MD who prescribed Benadryl.  Hives disappeared 27FEB but dev on back 28FEB.  RX=Pediapred, hives improving 01MAR.  Has sl rash intermingled w/ hives on back.
Rash, itching swelling txt self with BENADRYL and hydrocortisone creme. Seen on 9/29/14 with no rxn at vaccine site. Rash w back of shoulder (states vaccine site rxn had previously cleared.).
Pt. recv'd flu vaccine on 12/24/11 at approx 3 pm on 12/25/11 pt. awoke to extreme chills. Chills lasted 6-8 hours. Pt also experienced a low grade fever, & knee pain.
Patient just called 9/21/2021 stating that she had an injury  to her RIGHT arm, and that her doctor told her it was common from a vaccine. She stated that the doctor told her this type of thing keeps happening etc. I asked her if she had gotten any other vaccines since 6/18/2021 and she said no. I informed her the paperwork stated we administered in the left arm, she was very adamant that we did her right arm. I did review video to verify information on the paperwork and it looks like she did receive it in her Left arm as shown on the VAR. She claimed the injury was "frozen shoulder syndrome".  She also stated her doctor believes she will now need surgery.
CHIEF COMPLAINT Fever and sore throat    HISTORY OF PRESENT ILLNESS Patient  is a 71 y.o. male who presents with past medical history  (residing in adult foster care, wheelchair mobile) with medical conditions including HTN, diabetes type II, intellectual disability, schizophrenia, prior HIT (2012), prior stroke, bronchiectasis, anemia of chronic disease, CKD stage 5 (rising baseline creatinine most recently around 5.5, patient interested in peritoneal HD), renal mass (likely RCC, currently under surveillance, associated with pulmonary micronodules which may represent metastatic disease).    Patient presented to Hospital with complaint of cough, dyspnea, sore throat and fever.  He reports that there are many people in his group home that are COVID positive.  He denies any vomiting or diarrhea.  Plans in the emergency department were for him to undergo monoclonal antibodies and he had agreed, but lab results returned with a creatinine in noted at 6.14 and glucose of 49 (asymptomatic).  He was found to be COVID positive.  Hemoglobin 9.8, hematocrit 29.3, white blood cell count 7.8, glucose 48, sodium 138, potassium 4.2, bicarb 21, and gap of 19, creatinine of 6.14, BUN of 106, calcium 8.3, chest x-ray shows interval resolution of small bilateral pleural effusions and associated bibasilar atelectasis.  Given the concern for increasing creatinine in level above his baseline and hypoglycemia he was admitted to the hospital for further evaluation and treatment.   Patient was seen in room. He reports doing well and is eating dinner. He reports that his entire group home has come down with COVID and he started developing symptoms.  He denies any dizziness, lightheadedness, shaking related to his hypoglycemia.  He reports that he has not eaten anything since this morning, as he has been in the emergency department this entire time.  He denies any chills.  He reports his shortness of breath is only intermittent and denies any at this current time.  He denies any chest pain, nausea, vomiting and diarrhea constipation or urinary complaints.  He has remained on room air.  He endorses that he has been followed with outpatient Nephrology with the consideration of peritoneal hemodialysis given his recent rising creatinine levels.
Information has been received from a physician concerning a 6 year old female with no pertinent medical history who on 27-DEC-2000 was vaccinated with a dose of Varivax (lot # 635443/0498K). On 01-APR-2006 the patient experienced a chickenpox rash. The child presented to the physician's office with a "chickenpox" rash with less than 50 lesions. There was no treatment ordered and there was no fever or other symptoms. At the time of this report the patient was recovering. There was no product quality complaint involved. Additional information has been requested.
Terrible rash with raised welts, coalescing over 25% of body within 6 hrs of vaccination (Sunday evening) .  I took 75 mg Benadryl.   Next day continued with Benadryl and visited the local urgent care clinic and was prescribed prednisone (40 mg).   About 50% of body covered with about hives and coalescing welts.  Medical clinic told to go to ER or a doctor if problem persisted.   Telemed with doctor Monday continuing through today.  Placed on 10 mg of loratadine/day and 60 mg of prednisone,   for 5 days,  rash and raised coalescing welts continue for 6 days and started dissipating on day 7.   Tapering off prednisone,  Prescribed epi-pen too if breathing issue developed (breathing problems did not occur.)  Today is day 9 since vaccination.  rash still present over 20% of body a welts still "pop up".  I am still reacting to the vaccine
I received the shingles vaccine hoping it would help me - I have had 2 episodes a year for about 5 years, after the vaccine that accelerated to 5 episodes in 2008 and 3 this year with the last only 2 weeks apart so it made things worse and the back nerve pain is increasing in intensity each time absolute agony
Fever (101) Swelling, pain under arm that was vaccinated, lymph nodes Body chills Headache
Patient c/o burning sensation when receiving vaccine. Pain in arm muscle for two days. Injection site felt hot for three days. Patient c/o low grade fever for three days.
sinus issues; fatigue; This spontaneous case was reported by a patient and describes the occurrence of SINUS DISORDER (sinus issues) and FATIGUE (fatigue) in a 66-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced SINUS DISORDER (sinus issues) and FATIGUE (fatigue). At the time of the report, SINUS DISORDER (sinus issues) and FATIGUE (fatigue) had resolved.            Concomitant medications were not reported.  Patient experienced fatigue for about 2 days and then mild fatigue for the three days. Treatment medications were not reported.
I contracted COVID-19 on 06/15/2022 with symptoms of fatigue, myalgia, nausea, dizziness. abdominal pain, and diarrhea. I was not prescribed any medications. I was ill for 6 days before my symptoms began to resolve. I did have lingering symptoms of nausea and dizziness with persisted for 2 to 3 weeks, I am fully recovered with no lingering symptoms now.
12 x 8 cm area - redness, swollen, warm, tender, feels tiredness. Some hoarseness & rapid heart beat initially.
Had vaccine still got shingle; Got shingle; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient had vaccine and still got shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
I felt body aches all over, my skin hurt to the touch , the rim of my eyes feels burning . bottom of my feet hurts. I felt like the core of my body hurts. I felt like dying . even my hair hurts.  I took Tylenol around 8 pm. by 12 all the aches were gone , I felt better.
Patient expressed swelling, redness, warmth at the site the next morning (11/3/19)as well as body aches, subjective fever, tired, dizziness. Patient denies any difficulty breathing, swallowing, or noted rash elsewhere. States symptoms have mildly improved compared to yesterday, and it doesn't appear to be as "hard" over the administration site. Recommended to closely monitor for signs of infection and continued improvement, and discussed possible association with Prevnar and strict ER precautions were discussed.
This case was reported by a healthcare professional and described the occurrence of injection site redness in a subject of unspecified age and gender who was vaccinated with Flulaval (GlaxoSmithKline).  On an unspecified date in 2007 (between 18 September 2007 and 02 October 20007), the subject received unspecified dose of Flulaval (0.5 ml, unknown, left arm).  On the same date as vaccination with Flulaval, the subject experienced injection site redness, injection site pruritus, and swelling injection site.  Medical attention was required at the doctor's office.  The events were resolved on the same day of vaccination/ onset of the adverse events.  The healthcare professional considered the events were probably related to vaccination with Flulaval.  The nurse reported a total of four subjects who experienced similar reactions following administrations of Flulaval between 18 September 2007 and the time of reporting on 02 October 2007 (please see GSK reference numbers A0686373A, A0686378A, and A0686379A).  "Some" of the subjects experienced "swelling at the site of injection to about softball size".  The subjects had previously received influenza vaccinations and had not experienced adverse reactions "other than one patient who may have experienced redness at injection site".
Sore Left shoulder around shot site (deltoid mucsle).  Swollen lymph node in underarm (left arm) and tingling in left arm down to fingers.
Wrong vaccines administered for age range. Should have received Pfizer for ages 12+ years. Received Pfizer for ages 5-11 years. Patient notified by Nurse Manager.
Covid arm or vaccine arm. Swelling of right deltoid area and a little  bit on inside of armpit. Big red spot on skin on deltoid area. Red spot on deltoid area was itchy. Took children's Benadryl liquid, and itching went away.
Mother brought patient in for 2nd series of shots. States with first series began crying about 2 hrs after immun. administered. He screemed and cried a high-pitched cry continuously until about 11 PM, when he finally fell asleep. He was fine the next morning. Denies any other symptoms was given tylenol.
This spontaneous report as received from a medical assistant (M.A.) refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 18-JUN-2015, the patient was vaccinated with the third dose of improperly stored ROTATEQ oral liquid (lot # L000571, expiration date 26-JUL-2016) (dose unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Roughly 7-8 min after the vaccination,  my pulse began racing. It was 152. I requested help. My blood pressure had also skyrocketed. EKG was ok. No swelling, no itching, no difficulty breathing. However, blood pressure was significantly higher than anything ever experienced.  Hour later was still 169/92 (my norm is 110 or 120 over 70), and pulse rate still around 112-114. Not yet resolved. 9 hours later, pressure is coming down, but still 137/81 with pulse still at 99 while just sitting) usually in 70s.